There are reports that a 79-year-old patient received special access to the experimental obesity drug retatrutide, with some outlets suggesting it may have been a former US president. Democratic lawmakers are seeking information on who received the drug, with some specifically asking if it was given to the Trump administration. The White House has denied speculation that the drug was given to Trump for "compassionate use".